Scientists Identify Common Neural Fingerprint of Psychedelics in the Brain

Researchers have identified a consistent neurological signature, described as a neural fingerprint, that occurs in the human brain across the use of five different psychedelic substances. The findings, published in April 2026, suggest that these drugs share a common impact on brain behavior by increasing cross-talk between various brain systems.

The discovery is central to ongoing clinical trials investigating these substances as potential therapies for severe neurological and mental health conditions, including post-traumatic stress disorder, schizophrenia, and depression.

The Mega-Analysis Methodology

The findings resulted from an international mega-analysis that integrated 11 independent resting-state functional magnetic resonance imaging (fMRI) datasets. This study combined data from research groups across five countries and three continents to create a more reliable picture of how psychedelic substances temporarily rewire brain function.

The analysis focused on five specific psychedelic drugs: psilocybin, lysergic acid diethylamide (LSD), dimethyltryptamine (DMT), mescaline, and ayahuasca. To ensure consistency across the fragmented data from different sites, the researchers applied a uniform preprocessing pipeline and used a Bayesian hierarchical modeling framework.

Defining the Neural Fingerprint

The core signature identified by the researchers is a significant increase in functional connectivity between transmodal networks and unimodal networks. Specifically, the study found increased communication between the limbic, frontoparietal, and default networks (transmodal) and the somatomotor and visual networks (unimodal).

Under normal conditions, brain systems typically maintain a structured hierarchy where networks communicate strongly within themselves. The researchers found that psychedelics dissolve this established order, effectively flattening the hierarchy of brain systems.

All five drugs dissolve the common order, the usual hierarchy of brain systems. They flatten the hierarchy and that probably underlies what some people describe as this raw access to one’s own consciousness.

Dr. Danilo Bzdok, senior author from McGill University

This reduction in rigid structure means that brain networks become less isolated, allowing for the increased cross-talk that characterizes the psychedelic experience.

Subcortical and Cerebellar Involvement

Beyond the cortical organization, the study revealed that psychedelics selectively engage subcortical circuitry. Researchers observed altered coupling between sensorimotor networks and key subcortical regions, including the putamen, the caudate, and the thalamus.

The cerebellum also exhibited altered coupling with sensorimotor networks, indicating that the effects of these substances extend beyond the higher-order processing areas of the brain to include regions responsible for motor control and sensory integration.

Variability and Clinical Context

While the increase in connectivity between different networks was a common feature, the study found that reductions in within-network functional connectivity were more selective. Bayesian modeling indicated that these reductions were weak-to-moderate and showed substantial variability depending on the specific drug used and the network being analyzed.

These insights provide a scientific basis for understanding the mind-altering effects of psychedelics and how they might be leveraged for medical treatment. By identifying the specific ways these drugs reconfigure large-scale cortical organization, researchers can better understand the mechanisms that may lead to therapeutic breakthroughs in treating resistant mental health disorders.